These innovative medications , Tirzepatide , represent a remarkable advancement in addressing obesity and possibly other ailments . They are categorized as GLP-1 receptor stimulators, indicating they to emulate the natural GLP-1 substance , stimulating metabolic production and reducing food intake. Despite Tirzepatide each operates somewhat similar